Thyroxine-induced Expression of Pyroglutamyl Peptidase II and Inhibition of TSH Release Precedes Suppression of TRH MRNA and Requires Type 2 Deiodinase

Overview

Journal J Endocrinol

Specialty Endocrinology

Date 2011 Jul 27

PMID 21788297

Citations 14

Authors

Alessandro Marsili

Edith Sanchez

Praful Singru

John W Harney

Ann Marie Zavacki

Ronald M Lechan

P R Larsen

Affiliations

Soon will be listed here.

Abstract

Suppression of TSH release from the hypothyroid thyrotrophs is one of the most rapid effects of 3,3',5'-triiodothyronine (T(3)) or thyroxine (T(4)). It is initiated within an hour, precedes the decrease in TSHβ mRNA inhibition and is blocked by inhibitors of mRNA or protein synthesis. TSH elevation in primary hypothyroidism requires both the loss of feedback inhibition by thyroid hormone in the thyrotrophs and the positive effects of TRH. Another event in this feedback regulation may be the thyroid hormone-mediated induction of the TRH-inactivating pyroglutamyl peptidase II (PPII) in the hypothalamic tanycytes. This study compared the chronology of the acute effects of T(3) or T(4) on TSH suppression, TRH mRNA in the hypothalamic paraventricular nucleus (PVN), and the induction of tanycyte PPII. In wild-type mice, T(3) or T(4) caused a 50% decrease in serum TSH in hypothyroid mice by 5 h. There was no change in TRH mRNA in PVN over this interval, but there was a significant increase in PPII mRNA in the tanycytes. In mice with genetic inactivation of the type 2 iodothyronine deiodinase, T(3) decreased serum TSH and increased PPII mRNA levels, while T(4)-treatment was ineffective. We conclude that the rapid suppression of TSH in the hypothyroid mouse by T(3) occurs prior to a decrease in TRH mRNA though TRH inactivation may be occurring in the median eminence through the rapid induction of tanycyte PPII. The effect of T(4), but not T(3), requires the type 2 iodothyronine deiodinase.

Citing Articles

Intrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion.

Jing L, Zhang Q Front Endocrinol (Lausanne). 2022; 13:992883.

PMID: 36187113 PMC: 9519864. DOI: 10.3389/fendo.2022.992883.

The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?.

Charli J, Rodriguez-Rodriguez A, Hernandez-Ortega K, Cote-Velez A, Uribe R, Jaimes-Hoy L Front Pharmacol. 2020; 11:640.

PMID: 32457627 PMC: 7225337. DOI: 10.3389/fphar.2020.00640.

Tanycyte ablation in the arcuate nucleus and median eminence increases obesity susceptibility by increasing body fat content in male mice.

Yoo S, Cha D, Kim S, Jiang L, Cooke P, Adebesin M Glia. 2020; 68(10):1987-2000.

PMID: 32173924 PMC: 7423758. DOI: 10.1002/glia.23817.

Sex Dimorphic Responses of the Hypothalamus-Pituitary-Thyroid Axis to Maternal Separation and Palatable Diet.

Jaimes-Hoy L, Romero F, Charli J, Joseph-Bravo P Front Endocrinol (Lausanne). 2019; 10:445.

PMID: 31354623 PMC: 6637657. DOI: 10.3389/fendo.2019.00445.

Tanycytes and the Control of Thyrotropin-Releasing Hormone Flux Into Portal Capillaries.

Rodriguez-Rodriguez A, Lazcano I, Sanchez-Jaramillo E, Uribe R, Jaimes-Hoy L, Joseph-Bravo P Front Endocrinol (Lausanne). 2019; 10:401.

PMID: 31293518 PMC: 6603095. DOI: 10.3389/fendo.2019.00401.

References

Larsen P, Silva J, KAPLAN M . Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr Rev. 1981; 2(1):87-102. DOI: 10.1210/edrv-2-1-87. View

Fekete C, Lechan R . Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase. Front Neuroendocrinol. 2007; 28(2-3):97-114. PMC: 2000455. DOI: 10.1016/j.yfrne.2007.04.002. View

Bowers C, Lee K, Schally A . A study on the interaction of the thyrotropin-releasing factor and L-triiodothyronine: effects of puromycin and cycloheximide. Endocrinology. 1968; 82(1):75-82. DOI: 10.1210/endo-82-1-75. View

Shupnik M, Ridgway E, Chin W . Molecular biology of thyrotropin. Endocr Rev. 1989; 10(4):459-75. DOI: 10.1210/edrv-10-4-459. View

Tu H, Kim S, Salvatore D, Bartha T, Legradi G, Larsen P . Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology. 1997; 138(8):3359-68. DOI: 10.1210/endo.138.8.5318. View

Silva J, Larsen P . Peripheral metabolism of homologous thyrotropin in euthyroid and hypothyroid rats: acute effects of thyrotropin-releasing hormone, triiodothyronine, and thyroxine. Endocrinology. 1978; 102(6):1783-96. DOI: 10.1210/endo-102-6-1783. View

Sanchez E, Vargas M, Singru P, Pascual I, Romero F, Fekete C . Tanycyte pyroglutamyl peptidase II contributes to regulation of the hypothalamic-pituitary-thyroid axis through glial-axonal associations in the median eminence. Endocrinology. 2009; 150(5):2283-91. PMC: 2671897. DOI: 10.1210/en.2008-1643. View

Lechan R, Fekete C . Role of thyroid hormone deiodination in the hypothalamus. Thyroid. 2005; 15(8):883-97. DOI: 10.1089/thy.2005.15.883. View

Pohlenz J, Maqueem A, Cua K, Weiss R, Van Sande J, Refetoff S . Improved radioimmunoassay for measurement of mouse thyrotropin in serum: strain differences in thyrotropin concentration and thyrotroph sensitivity to thyroid hormone. Thyroid. 2000; 9(12):1265-71. DOI: 10.1089/thy.1999.9.1265. View

10.

Chiamolera M, Wondisford F . Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology. 2009; 150(3):1091-6. DOI: 10.1210/en.2008-1795. View

11.

Kadar A, Sanchez E, Wittmann G, Singru P, Fuzesi T, Marsili A . Distribution of hypophysiotropic thyrotropin-releasing hormone (TRH)-synthesizing neurons in the hypothalamic paraventricular nucleus of the mouse. J Comp Neurol. 2010; 518(19):3948-61. PMC: 2932658. DOI: 10.1002/cne.22432. View

12.

Heuer H, Schafer M, ODonnell D, Walker P, Bauer K . Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats. J Comp Neurol. 2000; 428(2):319-36. View

13.

Schneider M, Fiering S, Pallud S, Parlow A, St Germain D, Galton V . Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol. 2001; 15(12):2137-48. DOI: 10.1210/mend.15.12.0740. View

14.

Christoffolete M, Arrojo E Drigo R, Gazoni F, Tente S, Goncalves V, Amorim B . Mice with impaired extrathyroidal thyroxine to 3,5,3'-triiodothyronine conversion maintain normal serum 3,5,3'-triiodothyronine concentrations. Endocrinology. 2006; 148(3):954-60. DOI: 10.1210/en.2006-1042. View

15.

Heuer H, Ehrchen J, Bauer K, Schafer M . Region-specific expression of thyrotrophin-releasing hormone-degrading ectoenzyme in the rat central nervous system and pituitary gland. Eur J Neurosci. 1998; 10(4):1465-78. DOI: 10.1046/j.1460-9568.1998.00158.x. View

16.

Segerson T, Kauer J, WOLFE H, Mobtaker H, Wu P, Jackson I . Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus. Science. 1987; 238(4823):78-80. DOI: 10.1126/science.3116669. View

17.

Bowers C, Lee K, Schally A . Effect of actinomycin D on hormones that control the release of thyrotropin from the anterior pituitary glands of mice. Endocrinology. 1968; 82(2):303-10. DOI: 10.1210/endo-82-2-303. View

18.

Riskind P, Kolodny J, Larsen P . The regional hypothalamic distribution of type II 5'-monodeiodinase in euthyroid and hypothyroid rats. Brain Res. 1987; 420(1):194-8. DOI: 10.1016/0006-8993(87)90260-5. View

19.

Silva J, Larsen P . Pituitary nuclear 3,5,3'-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science. 1977; 198(4317):617-20. DOI: 10.1126/science.199941. View

20.

Sugrue M, Vella K, Morales C, Lopez M, Hollenberg A . The thyrotropin-releasing hormone gene is regulated by thyroid hormone at the level of transcription in vivo. Endocrinology. 2009; 151(2):793-801. PMC: 2817611. DOI: 10.1210/en.2009-0976. View